Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome
Acta Anaesthesiologica Scandinavica, 09/13/07
Faber., et al. - Vascular-type Ehlers-Danlos syndrome is an inherited connective tissue disorder resulting in an increased risk of serious peri-operative bleeding during surgery for spontaneous organ or vessel rupture. The excessive bleeding may result in coagulopathy, and thus compound the difficulty in securing surgical haemostasis. With the advent of recombinant factor VIIa, a new therapy has become available for the management of intractable surgical bleeding
| Previous Article | Next Article |
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
New Pain Guideline for Older Patients
JAMA, 07/01/09
Ketamine pretreatment to alleviate the pain of propofol injection: A randomized, double blind study
The Internet Journal of Anesthesiology, 06/22/09
The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial
Critical Care Medicine, 05/28/09
Article Search
Sponsor


See Latest Articles


